SimPath licenses novel cloning system from ORNL

SimPath2SimPath, a local start-up that pitched during Knoxville’s 2015 “Start-up Day,” has executed a license with Oak Ridge National Laboratory (ORNL) for a novel cloning system that generates and assembles the biological building blocks necessary to synthetically bioengineer new medicines and fuels. Click here to read the ORNL news release and look for a story profiling SimPath soon on

Stay connected with us on Twitter and LinkedIn. Article ideas and other suggestions should be sent to Include the name and contact information (phone and email) for follow-up.